Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 47590-47591 [2011-19863]
Download as PDF
<![CDATA[
47590
Federal Register / Vol. 76, No. 151 / Friday, August 5, 2011 / Notices
3a,b, 4a,c, 5a,b, 6b,c, 8a,b in Oncogene
28(5):651–61, 2009; RT–PCR and/or
ChIP experiments were included in six
(6) of eight (8) figures in this
publication.
Respondent has entered into a
Voluntary Exclusion Agreement
(Agreement). Respondent and the U.S.
Public Health Service (PHS) want to
conclude this matter without further
expenditure of time or other resources.
Respondent accepts ORI’s findings of
research misconduct as set forth above
but neither admits nor denies
committing research misconduct. The
Agreement does not constitute an
admission of liability on Respondent’s
part. Respondent agrees not to appeal
the jurisdiction of ORI or request a U.S.
Department of Health and Human
Services (HHS) administrative hearing
to review the findings as set forth in the
Agreement.
As a condition of the Agreement,
Respondent agrees that the Mol.
Endocrinol. 23(12):2075–85, 2009, and
Oncogene 28(5):651–61, 2009,
publications be retracted.
In entering into the Agreement, Dr.
Wang has voluntarily agreed for a
period of two (2) years, beginning on
July 18, 2011:
(1) To exclude himself from any
contracting or subcontracting with any
agency of the United States Government
and from eligibility or involvement in
nonprocurement programs of the United
States Government referred to as
‘‘covered transactions’’ pursuant to
HHS’ Implementation (2 CFR part 376 et
seq) of OMB Guidelines to Agencies on
Governmentwide Debarment and
Suspension, 2 CFR part 180 (collectively
the ‘‘Debarment Regulations’’); and
(2) To exclude himself from serving in
any advisory capacity to PHS, including
but not limited to service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT:
erowe on DSKG8SOYB1PROD with NOTICES
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John Dahlberg,
Director, Division of Investigative Oversight,
Office of Research Integrity.
[FR Doc. 2011–19930 Filed 8–4–11; 8:45 am]
BILLING CODE 4150–31–P
VerDate Mar<15>2010
15:16 Aug 04, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates
9 a.m.–5 p.m., September 21, 2011.
8 a.m.–4:30 p.m., September 22, 2011.
8 a.m.–2:30 p.m., September 23, 2011.
Place: CDC, Building 19, Auditorium B,
Tom Harkin Global Communications Center,
1600 Clifton Road, NE., Atlanta, Georgia
30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee provides advice
and guidance to the Secretary, HHS; the
Assistant Secretary for Health; and the
Director, CDC, regarding the formative
research, development, implementation and
evaluation of evidence-based activities
designed to prevent breast cancer
(particularly among those at heightened risk)
and promote the early detection and support
of young women who develop the disease.
The advice provided by the Committee will
assist in ensuring scientific quality,
timeliness, utility, and dissemination of
credible appropriate messages and resource
materials.
Matters to Be Discussed: The agenda will
include discussions on health
communications tools and resources related
to breast cancer in young women including
appropriate venues to educate women at
increased risk for developing breast cancer at
younger ages; and approaches to increase
awareness of clinicians/practitioners
regarding topics such as breast health,
symptoms, diagnosis, and treatment of breast
cancer in young women.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: In order to
expedite the security clearance process
required for entry into a Federal building, all
ACBCYW attendees must register for the
meeting online at least 21 days in advance at
https://www.cdc.gov/cancer/breast/
what_cdc_is_doing/meetings.htm. Please
complete all the required fields before
submitting your registration and submit no
later than August 29, 2011. Each meeting
day, attendees must provide CDC staff and
security with a driver’s license/state issued
identification, or passport.
Contact Person for More Information:
Temeika L. Fairley, PhD, Designated Federal
Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 5770
Buford Highway, NE., Mailstop K52, Atlanta,
Georgia 30341, Telephone: (770) 488–4518,
Fax: (770) 488–4760.
The Director, Management Analysis and
Services Office, has been delegated the
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and Agency for Toxic Substances
and Disease Registry.
Dated: July 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–19869 Filed 8–4–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates (All
times are Pacific Time):
8:15 a.m.–5 p.m., August 23, 2011.
8:15 a.m.–4:45 p.m., August 24, 2011.
8:15 a.m.–12:30 p.m., August 25, 2011.
Public Comment Times and Dates (All
times are Pacific Time):
5 p.m.–6 p.m.*, August 23, 2011.
5 p.m.–6:30 p.m.*, August 24, 2011.
*Please note that the public comment
periods may end before the times indicated,
following the last call for comments.
Members of the public who wish to provide
public comments should plan to attend
public comment sessions at the start times
listed.
Place: Courtyard by Marriott, 480
Columbia Point, Richland, Washington
99352, Telephone: (509) 942–9400, Fax: (509)
942–9401.
Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 with a pass code
of 9933701.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 150 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
E:\FR\FM\05AUN1.SGM
05AUN1
erowe on DSKG8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 151 / Friday, August 5, 2011 / Notices
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2011.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The agenda for
the Advisory Board meeting includes: NIOSH
Program Update and 10-Year Program
Review; Department of Labor (DOL) Program
Update; Department of Energy (DOE)
Program Update; Hanford Work Group
Update; SEC petitions for: W.R. Grace (Curtis
Bay, Maryland), Piqua Organic Moderated
Reactor (1963–1966), Y–12 (1948–1957),
Hangar 481 (Kirtland Air Force Base), Hooker
Electrochemical, Feed Materials Production
Center (Fernald, Ohio), Norton Company,
Savannah River Site, Pantex Plant, Vitro
Manufacturing (1959–1965), Ames
Laboratory (1942–1970); SEC Petition Status
Updates; Subcommittee and Work Group
Reports; and Board Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted in
accordance with the redaction policy
provided below. Any written comments
received will be provided at the meeting and
should be submitted to the contact person
below well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public website. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) Above
VerDate Mar<15>2010
15:16 Aug 04, 2011
Jkt 223001
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as outlined
in (a) Above will also appear with the agenda
for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in
(a) Above will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an individual
in making a statement reveals personal
information (e.g., medical information) about
themselves that information will not usually
be redacted. The NIOSH FOIA coordinator
will, however, review such revelations in
accordance with the Freedom of Information
Act and the Federal Advisory Committee Act
and if deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share
information with the Board but objects to
doing so in a public forum, the DFO will
work with that individual, in accordance
with the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
For Further Information Contact: Theodore
Katz, M.P.A., Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, MS E–20, Atlanta
Georgia 30333, Telephone: (513) 533–6800,
Toll Free: 1–800–CDC–INFO, E-mail:
dcas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–19863 Filed 8–4–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10392]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Correction
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
AGENCY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
47591
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a previously
approved collection; Title of
Information Collection: Consumer
Operated and Oriented (CO–OP)
Program; Use: The Consumer Operated
and Oriented Plan (CO–OP) program is
a new program, established by Section
1322 of the Affordable Care Act. This
program provides for loans to establish
at least one consumer-operated,
qualified nonprofit health insurance
issuer in each State. Issuers supported
by the CO–OP program will offer at least
one qualified health plan at the silver
level of benefits and one at the gold
level of benefits in the Affordable
Insurance Exchanges (Exchanges). At
least two-thirds of policies or contracts
offered by a CO–OP will be open to
individuals and small employers. Profits
generated by the nonprofit CO–OPs will
be used to lower premiums, improve
benefits, improve the quality of health
care delivered to their members, expand
enrollment, or otherwise contribute to
the stability of coverage offered by the
CO–OP. By increasing competition in
the health insurance market and
operating with a strong consumer focus,
the CO–OP program will provide
consumers more choices, greater plan
accountability, increased competition to
lower prices, and better models of care,
benefiting all consumers, not just CO–
OP members.
The CO–OP program will provide
nonprofits with loans to fund start-up
costs and State reserve requirements, in
the form of Start-up Loans and Solvency
Loans. An applicant may apply for (1)
Joint Start-up and Solvency Loans; or (2)
only a Solvency Loan. Start-up Loans
are intended to assist loan recipients
with the many start-up costs associated
with establishing a new health
insurance issuer. Solvency Loans are
intended to assist loan recipients with
meeting the solvency requirements of
States in which the applicant seeks to be
licensed to issue qualified health plans.
The Funding Opportunity
Announcement (FOA) was released on
July 28, 2011. Applications will be due
on October 17, 2011 and on a quarterly
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 76, Number 151 (Friday, August 5, 2011)]
[Notices]
[Pages 47590-47591]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19863]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All times are Pacific
Time):
8:15 a.m.-5 p.m., August 23, 2011.
8:15 a.m.-4:45 p.m., August 24, 2011.
8:15 a.m.-12:30 p.m., August 25, 2011.
Public Comment Times and Dates (All times are Pacific Time):
5 p.m.-6 p.m.*, August 23, 2011.
5 p.m.-6:30 p.m.*, August 24, 2011.
*Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of
the public who wish to provide public comments should plan to attend
public comment sessions at the start times listed.
Place: Courtyard by Marriott, 480 Columbia Point, Richland,
Washington 99352, Telephone: (509) 942-9400, Fax: (509) 942-9401.
Audio Conference Call via FTS Conferencing. The USA toll-free,
dial-in number is 1-866-659-0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
which have been promulgated by the Department of
[[Page 47591]]
Health and Human Services (HHS) as a final rule, advice on methods
of dose reconstruction which have also been promulgated by HHS as a
final rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2011.
Purpose: This Advisory Board is charged with (a) providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters To Be Discussed: The agenda for the Advisory Board
meeting includes: NIOSH Program Update and 10-Year Program Review;
Department of Labor (DOL) Program Update; Department of Energy (DOE)
Program Update; Hanford Work Group Update; SEC petitions for: W.R.
Grace (Curtis Bay, Maryland), Piqua Organic Moderated Reactor (1963-
1966), Y-12 (1948-1957), Hangar 481 (Kirtland Air Force Base),
Hooker Electrochemical, Feed Materials Production Center (Fernald,
Ohio), Norton Company, Savannah River Site, Pantex Plant, Vitro
Manufacturing (1959-1965), Ames Laboratory (1942-1970); SEC Petition
Status Updates; Subcommittee and Work Group Reports; and Board Work
Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted in accordance with the redaction policy provided below.
Any written comments received will be provided at the meeting and
should be submitted to the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment): (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public website. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) Above will be
displayed on the table where individuals sign up to make public
comments; (c) A statement such as outlined in (a) Above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) Above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share information with the Board
but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee
Act, to find a way that the Board can hear such comments.
For Further Information Contact: Theodore Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta
Georgia 30333, Telephone: (513) 533-6800, Toll Free: 1-800-CDC-INFO,
E-mail: dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: July 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-19863 Filed 8-4-11; 8:45 am]
BILLING CODE 4163-18-P
